The Big Ethical Questions for Artificial Intelligence in Healthcare

AI in healthcare is developing rapidly, with many applications currently in use or in development in the UK and worldwide. The Nuffield Council on Bioethics examines the current and potential applications of AI in healthcare, and the ethical issues arising from its use, in a new briefing note, Artificial Intelligence (AI) in healthcare and research, published today.

There is much hope and excitement surrounding the use of AI in healthcare. It has the potential to make healthcare more efficient and patient-friendly; speed up and reduce errors in diagnosis; help patients manage symptoms or cope with chronic illness; and help avoid human bias and error. But there are some important questions to consider: who is responsible for the decisions made by AI systems? Will increasing use of AI lead to a loss of human contact in care? What happens if AI systems are hacked?

The briefing note outlines the ethical issues raised by the use of AI in healthcare, such as:

  • the potential for AI to make erroneous decisions;
  • who is responsible when AI is used to support decision-making;
  • difficulties in validating the outputs of AI systems;
  • the risk of inherent bias in the data used to train AI systems;
  • ensuring the security and privacy of potentially sensitive data;
  • securing public trust in the development and use of AI technology;
  • effects on people's sense of dignity and social isolation in care situations;
  • effects on the roles and skill-requirements of healthcare professionals; and
  • the potential for AI to be used for malicious purposes.

Hugh Whittall, Director of the Nuffield Council on Bioethics, says: "The potential applications of AI in healthcare are being explored through a number of promising initiatives across different sectors - by industry, health sector organisations and through government investment. While their aims and interests may vary, there are some common ethical issues that arise from their work.

"Our briefing note outlines some of the key ethical issues that need to be considered if the benefits of AI technology are to be realised, and public trust maintained. These are live questions that set out an agenda for newly-established bodies like the UK Government Centre for Data Ethics and Innovation, and the Ada Lovelace Institute. The challenge will be to ensure that innovation in AI is developed and used in a ways that are transparent, that address societal needs, and that are consistent with public values."

For further information, please visit:
http://nuffieldbioethics.org/project/briefing-notes/artificial-intelligence-ai-healthcare-research

About The Nuffield Council on Bioethics

The Nuffield Council on Bioethics is an independent body that has been advising policy makers on ethical issues in bioscience and medicine for more than 25 years. As well as being a key UK partner on international networks of advisory bodies, the Council has an international reputation for advising policy-makers and stimulating debate in bioethics. The Council is funded by the Nuffield Foundation, the Medical Research Council, and Wellcome.

This is the third in a new series of bioethics briefing notes published by the Council. The previous notes focused on The search for a treatment for ageing and Whole genome sequencing of babies. We will publish further bioethics briefing notes this year on topics including the use of identification biometrics.

The Ada Lovelace Institute was announced by the Nuffield Foundation in March 2018. When the Institute becomes fully established, it will examine the ethical and social issues arising from the use of data, algorithms, and artificial intelligence, and ensure they are harnessed for social well-being.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...